Literature DB >> 23313362

A quantitative allele-specific PCR test for the BRAF V600E mutation using a single heterozygous control plasmid for quantitation: a model for qPCR testing without standard curves.

Philippe Szankasi1, N Scott Reading, Cecily P Vaughn, Josef T Prchal, David W Bahler, Todd W Kelley.   

Abstract

We describe a novel method for mutant allele quantitation using allele-specific PCR. The method uses a heterozygous plasmid containing one wild-type and one mutant sequence as a calibrator that is run at a single concentration, with each quantitative allele-specific PCR run. PCR data from both calibrator alleles, together with predetermined PCR efficiencies, are used to quantitate the mutant allele burden in unknown specimens. We demonstrate the utility of this method by using it to calculate BRAF V600E allele frequencies in cases of hairy-cell leukemia and show that it generates data that are comparable to those obtained via allele quantitation using conventional standard curves over a wide range of allelic ratios. This method is not subject to errors that may be introduced in traditional standard curves as the result of variations in pippetting or errors in the calculation of the absolute copy numbers of standards. Furthermore, it simplifies the workflow in the clinical laboratory and would provide significant advantages for efforts to standardize clinical quantitative PCR testing.
Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313362      PMCID: PMC5808148          DOI: 10.1016/j.jmoldx.2012.11.005

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  24 in total

1.  Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.

Authors:  Liqiang Xi; Evgeny Arons; Winnifred Navarro; Katherine R Calvo; Maryalice Stetler-Stevenson; Mark Raffeld; Robert J Kreitman
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

2.  The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.

Authors:  A Fariña-Sarasqueta; G van Lijnschoten; E Moerland; G-J Creemers; V E P P Lemmens; H J T Rutten; A J C van den Brule
Journal:  Ann Oncol       Date:  2010-05-25       Impact factor: 32.976

Review 3.  Guilty as charged: B-RAF is a human oncogene.

Authors:  Mathew J Garnett; Richard Marais
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

4.  Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype.

Authors:  S E Langabeer; D O'Brien; S Liptrot; C M Flynn; P J Hayden; E Conneally; P V Browne; E Vandenberghe
Journal:  Int J Lab Hematol       Date:  2012-02-07       Impact factor: 2.877

Review 5.  PCR amplification of specific alleles: rapid detection of known mutations and polymorphisms.

Authors:  C D Bottema; S S Sommer
Journal:  Mutat Res       Date:  1993-07       Impact factor: 2.433

6.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

7.  High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies.

Authors:  Elaine M Boyd; Anthony J Bench; Mars B van 't Veer; Penny Wright; David M Bloxham; George A Follows; Mike A Scott
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

8.  Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.

Authors:  Cecily P Vaughn; Scott D Zobell; Larissa V Furtado; Christine L Baker; Wade S Samowitz
Journal:  Genes Chromosomes Cancer       Date:  2011-02-08       Impact factor: 5.006

9.  JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.

Authors:  Giovanni Barosi; Gaetano Bergamaschi; Monia Marchetti; Alessandro M Vannucchi; Paola Guglielmelli; Elisabetta Antonioli; Margherita Massa; Vittorio Rosti; Rita Campanelli; Laura Villani; Gianluca Viarengo; Elisabetta Gattoni; Giancarla Gerli; Giorgina Specchia; Carmine Tinelli; Alessandro Rambaldi; Tiziano Barbui
Journal:  Blood       Date:  2007-08-21       Impact factor: 22.113

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  10 in total

1.  Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma.

Authors:  Jonathan C Dudley; Grzegorz T Gurda; Li-Hui Tseng; Derek A Anderson; Guoli Chen; Janis M Taube; Christopher D Gocke; James R Eshleman; Ming-Tseh Lin
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

2.  Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.

Authors:  Alessandro Broccoli; Carolina Terragna; Laura Nanni; Marina Martello; Silvia Armuzzi; Claudio Agostinelli; Alice Morigi; Beatrice Casadei; Cinzia Pellegrini; Vittorio Stefoni; Elena Sabattini; Lisa Argnani; Pier Luigi Zinzani
Journal:  Hematol Oncol       Date:  2021-10-15       Impact factor: 4.850

3.  Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia.

Authors:  Rimma Berenstein; Igor Wolfgang Blau; Nikola Suckert; Claudia Baldus; Antonio Pezzutto; Bernd Dörken; Olga Blau
Journal:  J Exp Clin Cancer Res       Date:  2015-05-22

4.  High-resolution melting analysis for accurate detection of BRAF mutations: a systematic review and meta-analysis.

Authors:  Dong Chen; Yan-Yan Wang; Zheng-Ran Chuai; Jun-Fu Huang; Yun-Xia Wang; Kai Liu; Li-Qun Zhang; Zhao Yang; Da-Chuan Shi; Qian Liu; Qing Huang; Wei-Ling Fu
Journal:  Sci Rep       Date:  2014-02-25       Impact factor: 4.379

5.  Optimized Multiplex Detection of 7 KRAS Mutations by Taqman Allele-Specific qPCR.

Authors:  Andrea Orue; Manuel Rieber
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

6.  Potential role of AKT/mTOR signalling proteins in hairy cell leukaemia: association with BRAF/ERK activation and clinical outcome.

Authors:  Eleftheria Lakiotaki; Georgia Levidou; Maria K Angelopoulou; Christos Adamopoulos; Gerassimos Pangalis; George Rassidakis; Theodoros Vassilakopoulos; Gabriella Gainaru; Pagona Flevari; Sotirios Sachanas; Angelica A Saetta; Athanasia Sepsa; Maria Moschogiannis; Christina Kalpadakis; Nikolaos Tsesmetzis; Vassilios Milionis; Ilenia Chatziandreou; Irene Thymara; Panayiotis Panayiotidis; Maria Dimopoulou; Eleni Plata; Konstantinos Konstantopoulos; Efstratios Patsouris; Christina Piperi; Penelope Korkolopoulou
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

Review 7.  Current Update of Laboratory Molecular Diagnostics Advancement in Management of Colorectal Cancer (CRC).

Authors:  Siew-Wai Pang; Noel Jacques Awi; Subasri Armon; Wendy Wan-Dee Lim; John Seng-Hooi Low; Kaik-Boo Peh; Suat-Cheng Peh; Sin-Yeang Teow
Journal:  Diagnostics (Basel)       Date:  2019-12-23

8.  A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma.

Authors:  Anna Richter; Fabienne Grieu; Amerigo Carrello; Benhur Amanuel; Kateh Namdarian; Aleksandra Rynska; Amanda Lucas; Victoria Michael; Anthony Bell; Stephen B Fox; Chelsee A Hewitt; Hongdo Do; Grant A McArthur; Stephen Q Wong; Alexander Dobrovic; Barry Iacopetta
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037

Review 10.  Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective.

Authors:  Guoli Chen; Zhaohai Yang; James R Eshleman; George J Netto; Ming-Tseh Lin
Journal:  Biomed Res Int       Date:  2016-09-06       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.